Pharmacokinetics, COX-2 specificity, and tolerability of supratherapeutic doses of rofecoxib in humans
M. Depré, E. Ehrich, A. Van Hecken, I. De Lepeleire, A. Dallob, P. Wong, A. Porras, B. J. Gertz, P. J. De SchepperVolume:
56
Language:
english
Pages:
8
DOI:
10.1007/s002280050736
Date:
May, 2000
File:
PDF, 155 KB
english, 2000